139 related articles for article (PubMed ID: 9739758)
1. The papillomavirus E6 proteins.
Rapp L; Chen JJ
Biochim Biophys Acta; 1998 Aug; 1378(1):F1-19. PubMed ID: 9739758
[TBL] [Abstract][Full Text] [Related]
2. Cell-restricted immortalization by human papillomavirus correlates with telomerase activation and engagement of the hTERT promoter by Myc.
Liu X; Dakic A; Chen R; Disbrow GL; Zhang Y; Dai Y; Schlegel R
J Virol; 2008 Dec; 82(23):11568-76. PubMed ID: 18818322
[TBL] [Abstract][Full Text] [Related]
3. Repression of the human papillomavirus E6 gene initiates p53-dependent, telomerase-independent senescence and apoptosis in HeLa cervical carcinoma cells.
Horner SM; DeFilippis RA; Manuelidis L; DiMaio D
J Virol; 2004 Apr; 78(8):4063-73. PubMed ID: 15047823
[TBL] [Abstract][Full Text] [Related]
4. Myc and human papillomavirus type 16 E7 genes cooperate to immortalize human keratinocytes.
Liu X; Disbrow GL; Yuan H; Tomaic V; Schlegel R
J Virol; 2007 Nov; 81(22):12689-95. PubMed ID: 17804506
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activation by the E6 gene product of human papillomavirus type 16.
Klingelhutz AJ; Foster SA; McDougall JK
Nature; 1996 Mar; 380(6569):79-82. PubMed ID: 8598912
[TBL] [Abstract][Full Text] [Related]
6. Bmi-1 cooperates with human papillomavirus type 16 E6 to immortalize normal human oral keratinocytes.
Kim RH; Kang MK; Shin KH; Oo ZM; Han T; Baluda MA; Park NH
Exp Cell Res; 2007 Feb; 313(3):462-72. PubMed ID: 17161394
[TBL] [Abstract][Full Text] [Related]
7. Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7.
McMurray HR; McCance DJ
J Virol; 2004 Jun; 78(11):5698-706. PubMed ID: 15140967
[TBL] [Abstract][Full Text] [Related]
8. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
[TBL] [Abstract][Full Text] [Related]
10. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development.
Pan H; Griep AE
Genes Dev; 1994 Jun; 8(11):1285-99. PubMed ID: 7926731
[TBL] [Abstract][Full Text] [Related]
11. Degradation of p53 only is not sufficient for the growth stimulatory effect of human papillomavirus 16 E6 oncoprotein in human embryonic fibroblasts.
Ishiwatari H; Hayasaka N; Inoue H; Yutsudo M; Hakura A
J Med Virol; 1994 Nov; 44(3):243-9. PubMed ID: 7852968
[TBL] [Abstract][Full Text] [Related]
12. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
[TBL] [Abstract][Full Text] [Related]
13. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of HPV E6 proteins in cellular transformation.
Huibregtse JM; Beaudenon SL
Semin Cancer Biol; 1996 Dec; 7(6):317-26. PubMed ID: 9284524
[TBL] [Abstract][Full Text] [Related]
15. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites.
Oh ST; Kyo S; Laimins LA
J Virol; 2001 Jun; 75(12):5559-66. PubMed ID: 11356963
[TBL] [Abstract][Full Text] [Related]
17. Papillomavirus E6 and E7 proteins and their cellular targets.
Wise-Draper TM; Wells SI
Front Biosci; 2008 Jan; 13():1003-17. PubMed ID: 17981607
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus E6 proteins mediate resistance to interferon-induced growth arrest through inhibition of p53 acetylation.
Hebner C; Beglin M; Laimins LA
J Virol; 2007 Dec; 81(23):12740-7. PubMed ID: 17898049
[TBL] [Abstract][Full Text] [Related]
19. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
[TBL] [Abstract][Full Text] [Related]
20. Microarray analysis identifies differentiation-associated genes regulated by human papillomavirus type 16 E6.
Duffy CL; Phillips SL; Klingelhutz AJ
Virology; 2003 Sep; 314(1):196-205. PubMed ID: 14517073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
